Treatment of follicular lymphoma with antibody CD20 -CLE 2016 2EME VAGUE (Q3682030): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): The objective of the project “Treatment of follicular lymphomas with anti-CD20 antibodies” is to develop quantitative imaging tools for the evaluation of effectiveness by light sheet microscopy., translated_summary) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
Treatment of follicular lymphoma with antibody CD20 -CLE 2016 2EME VAGUE | |||
Revision as of 18:46, 18 November 2021
Project Q3682030 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of follicular lymphoma with antibody CD20 -CLE 2016 2EME VAGUE |
Project Q3682030 in France |
Statements
89,537.0 Euro
0 references
419,424.0 Euro
0 references
21.35 percent
0 references
1 January 2017
0 references
31 December 2018
0 references
Centre National de la Recherche Scientifique
0 references
Le projet "Traitement des lymphomes folliculaires par des anticorps anti-CD20" a pour objectif le développement d'outils d'imagerie quantitative pour l'évaluation d'efficacité par microscopie à feuille de lumière. (French)
0 references
The objective of the project “Treatment of follicular lymphomas with anti-CD20 antibodies” is to develop quantitative imaging tools for the evaluation of effectiveness by light sheet microscopy. (English)
18 November 2021
0 references
Identifiers
MP0008755
0 references